Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects. Hohenstein AC, Gallegos J, Dang M, Groegler J, et al. Diabetes 2025 Jan 16:db240611. doi: 10.2337/db24-0611.

Read + Share

Amedeo Smart

Independent Medical Education

Hohenstein AC, Gallegos J, Dang M, Groegler J, et al. Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects. Diabetes 2025 Jan 16:db240611. doi: 10.2337/db24-0611.
PMID: 39820647